Clinical trial
Efficacy of Intra-Articular Vitamin D3 Injection for Treatment of Temporomandibular Joint Osteoarthritis: A Randomized Clinical Trial
NCT07929103 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Intra-Articular Vitamin D3 Injection for Treatment of Temporomandibular Joint Osteoarthritis: A Randomized Clinical Trial
- Lead sponsor
- Cairo University
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- July 1, 2026
- Completion date
- June 30, 2027
- Enrollment
- 26 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
temporomandibular joint osteoarthritis
Arms
As registered; 2 arms.
-
Group will be injected with Vitamin D3
Joint will be injected with 1ml of vitamin D3 ( Cholecalciferol 200.000 IU )
-
Group will be injected with Normal Saline
Joint will be injected with 1ml of normal saline
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Change from Baseline in Pain intensity will be assessed using the Visual Analog Scale (VAS), ranging from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. Higher scores indicate greater pain intensity (worse outcome)
Lead sponsor's other trials
Cairo University, most recent start first.
+4,945 more trials See the organization page